Brigatinib + Cyp3a Inducers Interaction
Moderateinteraction on record
Description
Coadministration decreases brigatinib plasma concentrations, which may decrease the efficacy of ALUNBRIG. Coadministration should be avoided.
Mechanism
CYP3A induction decreases brigatinib exposure
Source: NLP:brigatinib